Takeda Research Investment

www.tri-takeda.com

Takeda Research Investment, Inc. (TRI) is the corporate venture arm of Takeda Pharmaceutical Company, Ltd., with headquarters in Osaka, Japan. TRI, situated in the heart of Silicon Valley’s investment community, typically invests in early stage biopharmaceutical and biotechnology companies in North America, Canada and Europe. The aim is to inject capital to help proven management teams translate quality concepts into reality, and provide Takeda with early access to next-generation technologies and therapeutic products. TRI’s portfolio companies are focused on areas of key strategic importance to Takeda, with an emphasis on technologies and therapeutics that offer the promise of delivering new, innovative medicines in oncology, cardiovascular disease, central nervous system disorders and metabolic diseases.